A Democratic push in Congress to cap insulin costs for patients is gaining momentum. It may be a sign that some in the party are giving up on trying to pass comprehensive drug pricing legislation and focusing now on trying to pass what they think is most feasible, to give themselves an achievement to point to in their re-election campaigns.
White House Press Secretary Jen Psaki said yesterday that President Biden will talk about “lowering costs for prescription drugs” in his State of the Union message tonight. He might clarify his preferred strategy for moving drug pricing legislation through Congress.
A Democratic push in Congress to cap insulin costs for patients is gaining momentum.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
